Is rectal indomethacin ineffective in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in the general population?

Affiliations

¹ The Second Clinical Medical School of Southern Medical University, Guangdong, China.
² Department of Gastroenterology, First People's Hospital of Foshan Affiliated to Sun Yat-sen University, Guangdong, China.

Comment

Chongrong Shen et al. Dig Endosc. 2017 May.

. 2017 May;29(3):383-384.

doi: 10.1111/den.12787. Epub 2017 Feb 13.

¹ The Second Clinical Medical School of Southern Medical University, Guangdong, China.
² Department of Gastroenterology, First People's Hospital of Foshan Affiliated to Sun Yat-sen University, Guangdong, China.

No abstract available

Comment in

Reply to Letter to the Editor of Digestive Endoscopy.
Feng Y, Zhu X, Yang A. Feng Y, et al. Dig Endosc. 2017 May;29(3):384-385. doi: 10.1111/den.12815. Epub 2017 Feb 15. Dig Endosc. 2017. PMID: 28112449 No abstract available.

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.
Inamdar S, Han D, Passi M, Sejpal DV, Trindade AJ. Inamdar S, et al. Gastrointest Endosc. 2017 Jan;85(1):67-75. doi: 10.1016/j.gie.2016.08.034. Epub 2016 Sep 6. Gastrointest Endosc. 2017. PMID: 27612923
Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y, Navaneethan U, Zhu X, Varadarajulu S, Schwartz I, Hawes R, Hasan M, Yang A. Feng Y, et al. Dig Endosc. 2017 May;29(3):272-280. doi: 10.1111/den.12779. Epub 2017 Jan 3. Dig Endosc. 2017. PMID: 27914176 Review.